PubMed (cited) for id: 610984

Year	Number of Results
1970	2
1971	1
1972	1
1977	1
1994	1
1996	1
1999	1
2003	1
2006	2
2007	1
2024	0

1

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F. Servais A, et al. J Med Genet. 2007 Mar;44(3):193-9. doi: 10.1136/jmg.2006.045328. Epub 2006 Oct 3. J Med Genet. 2007. PMID: 17018561 Free PMC article.

2

Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family.

Grumach AS, Leitão MF, Arruk VG, Kirschfink M, Condino-Neto A. Grumach AS, et al. Clin Exp Immunol. 2006 Feb;143(2):297-304. doi: 10.1111/j.1365-2249.2005.02988.x. Clin Exp Immunol. 2006. PMID: 16412054 Free PMC article.

3

Molecular characterization of homozygous hereditary factor I deficiency.

Baracho GV, Nudelman V, Isaac L. Baracho GV, et al. Clin Exp Immunol. 2003 Feb;131(2):280-6. doi: 10.1046/j.1365-2249.2003.02077.x. Clin Exp Immunol. 2003. PMID: 12562389 Free PMC article.

4

Glomerulonephritis in a patient with complement factor I deficiency.

Sadallah S, Gudat F, Laissue JA, Spath PJ, Schifferli JA. Sadallah S, et al. Am J Kidney Dis. 1999 Jun;33(6):1153-7. doi: 10.1016/S0272-6386(99)70155-1. Am J Kidney Dis. 1999. PMID: 10352206

5

The molecular basis of hereditary complement factor I deficiency.

Vyse TJ, Morley BJ, Bartok I, Theodoridis EL, Davies KA, Webster AD, Walport MJ. Vyse TJ, et al. J Clin Invest. 1996 Feb 15;97(4):925-33. doi: 10.1172/JCI118515. J Clin Invest. 1996. PMID: 8613545 Free PMC article.

6

Hereditary complement factor I deficiency.

Vyse TJ, Späth PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ. Vyse TJ, et al. QJM. 1994 Jul;87(7):385-401. QJM. 1994. PMID: 7922290 Free article. Review.

7

Deficiency of C3 inactivator in man.

Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Abramson N, et al. J Immunol. 1971 Jul;107(1):19-27. J Immunol. 1971. PMID: 4997111 No abstract available.

8

Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Alper CA, Rosen FS, Lachmann PJ. Alper CA, et al. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910-3. doi: 10.1073/pnas.69.10.2910. Proc Natl Acad Sci U S A. 1972. PMID: 4507613 Free PMC article.

9

Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).

Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS. Alper CA, et al. N Engl J Med. 1970 Feb 12;282(7):349-54. doi: 10.1056/nejm197002122820701. N Engl J Med. 1970. PMID: 4188976 No abstract available.

10

Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.

Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS. Alper CA, et al. J Clin Invest. 1970 Nov;49(11):1975-85. doi: 10.1172/JCI106417. J Clin Invest. 1970. PMID: 4097977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year